Dr. Andrew Lewis Featured in PharmTech's "Pharma Fundamentals: Utilizing Artificial Intelligence in Drug Development"
The utilization of artificial intelligence (AI) in the pharmaceutical industry is developing quickly. In drug development, the use of AI in formulation is a shift from traditional trial-and-error methods to a more data-driven, accelerated approach. AI is being utilized to bridge the gap between drug discovery and clinical trials, optimizing how a molecule is turned into a viable drug product.
AI is helping to compress drug development timelines by enabling faster data analysis and predictive modeling. Researchers can now design new molecules in weeks rather than months. AI-driven workflows for target identification have yielded an average time savings of 28%.
Read the full article on PharmTech's website here.